US 11795232
Engineered transferrin receptor binding polypeptides
granted A61KA61K38/00
Quick answer
US patent 11795232 (Engineered transferrin receptor binding polypeptides) held by DENALI THERAPEUTICS INC. expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K38/00